ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Funds Proteomic Technology Assessment Grants.

September 29, 2006

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

January 23, 1976

Stovall To Step Down As NCCS President At End Of 2008.

September 21, 2007

NSABP Agrees To Three-Month Search for Chairman Candidates, Review Of Plans

June 10, 1994

NCI Reorganization Proposals Create opposition Among Some Advisors

June 17, 1988

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995